Latest Articles

General Oncology

ASCO Statement on Increasing the Number of Older Patients in Clinical Trials

ASCO Statement on Increasing the Number of Older Patients in Clinical Trials

While most cancer drugs are prescribed to older adults, they are underrepresented in clinical trials.

Hematologic Cancers Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology

Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology

[Cancer Control] Molecular testing is entrenched in the workup and management of hematological malignancies.

Prostate Cancer A Decade of Dramatic Change in the Treatment of Prostate Cancer

A Decade of Dramatic Change in the Treatment of Prostate Cancer

Numerous drug approvals for treatment of prostate cancer over the last decade hold hope for patients, but more research is needed to convert it to a chronic disease.

Lung Cancer Unregulated E-Cigarettes Called Unacceptable by ASCO

Unregulated E-Cigarettes Called Unacceptable by ASCO

Despite reports to the FDA regarding adverse events of e-cigarettes and concerns from health organizations, sales continue without regulatory oversight.

Breast Cancer TARGIT-A: Challenges in Shifting the Paradigm of Whole Breast Radiation

TARGIT-A: Challenges in Shifting the Paradigm of Whole Breast Radiation

Results from the international, noninferiority phase 3 TARGIT-A trial continue to be questioned by researchers and patient advocacy groups.

Chronic Lymphocytic Leukemia New Drug Approvals Bring Hope, Challenges in the Treatment of Chronic Leukemia

New Drug Approvals Bring Hope, Challenges in the Treatment of Chronic Leukemia

The approvals of obinutuzumab, ibrutinib, and idelalisib provide clinicians with new treatment options for patients with chronic lymphocytic leukemia (CLL).

Prostate Cancer Study Suggests 90% of Advanced Prostate Cancers May Have Anomaly that May Influence Treatment

Study Suggests 90% of Advanced Prostate Cancers May Have Anomaly that May Influence Treatment

A new study highlights the need for genetic counseling, which could help determine treatment options for certain patients.

Gastrointestinal Cancers Surveillance for asymptomatic recurrence in resected stage III colon cancer: does it result in a more favorable outcome?

Surveillance for asymptomatic recurrence in resected stage III colon cancer: does it result in a more favorable outcome?

[Journal of Gastrointestinal Oncology] This study evaluates survival outcomes of intensive surveillance post colorectal cancer (CRC) resection in a modern, population-based cohort study.

Breast Cancer Partial Breast Irradiation Provides "Excellent Long-term Local Control"

Partial Breast Irradiation Provides "Excellent Long-term Local Control"

Is targeting the entire breast necessary to the success of adjuvant radiotherapy?

General Oncology ASCO Releases Guideline Updates for the Use of Colony-stimulating Factors

ASCO Releases Guideline Updates for the Use of Colony-stimulating Factors

ASCO updates Clinical Practice Guidelines for the use of hematopoietic colony-stimulating factors (CSFs).

General Oncology Study Suggests Caution with Information Sharing of Older Patients

Study Suggests Caution with Information Sharing of Older Patients

Sharing health information about an older patient with family may have unintended consequences.

Renal Cell Carcinoma Deferred Systemic Therapy Reasonable for Selected Renal Cell Carcinoma Patients

Deferred Systemic Therapy Reasonable for Selected Renal Cell Carcinoma Patients

Delaying use of new targeted therapies may result in improved quality of life without adversely affecting outcomes.

Viewpoints Tiny Particles May Serve as Non-Invasive Tool for Detecting Early Stage Pancreatic Cancer

Tiny Particles May Serve as Non-Invasive Tool for Detecting Early Stage Pancreatic Cancer

A non-invasive diagnostic test using the GPC1 gene may soon be used to detect pancreatic cancer and track high-risk groups.

Viewpoints Afatinib May Be Second-Line Option for Advanced Lung Squamous Cell Carcinoma

Afatinib May Be Second-Line Option for Advanced Lung Squamous Cell Carcinoma

Afatinib could be an additional option for the second-line treatment of patients with advanced squamous cell carcinoma of the lung.

Viewpoints Screening Mammography Leads to Overdiagnosis in Breast Cancer

Screening Mammography Leads to Overdiagnosis in Breast Cancer

Screening mammography does not impact the overall breast cancer death rate and can lead to overdiagnosis.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs